The inflammatory myositis diagnosis market comprises diagnostic tests that help identify inflammatory muscle diseases such as dermatomyositis and polymyositis. Some common diagnostic tests employed in the market include MRI, electromyography, muscle biopsy, blood tests, and others. The rising prevalence of inflammatory muscle diseases due to genetic and environmental factors has been fueling demand for accurate diagnostic tests. As per estimates, over 100,000 people in the US suffer from different types of myositis.
The inflammatory myositis diagnosis market is estimated to be valued at USD 608 million in 2024 and is expected to reach USD 900 million by 2031, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
Key players operating in the inflammatory myositis diagnosis market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. Second paragraph is talking about the key opportunities in market and third paragraph is talking about global expansion in the market.
Some of the major opportunities in the Inflammatory Myositis Diagnosis Market include development of non-invasive diagnostic tests, growing myositis-focused research, and collaboration with patient advocacy groups. Given the increasing burden of inflammatory muscle diseases worldwide, key players are expanding their geographic presence in emerging markets like Asia Pacific and Latin America. Several partnerships and acquisitions have also been announced to strengthen global footprint.
Market drivers
Growing research into the pathophysiology of myositis Rising accessibility of advanced diagnostic techniques Increasing awareness about inflammatory muscle diseases Growing geriatric population susceptible to autoimmune conditions
Market restraints
High cost of diagnostic tests limiting adoption in low income countries Lack of disease-specific biomarkers challenging early diagnosis Social stigmas associated with muscle weakness decreasing healthcare seeking
Segment Analysis
The inflammatory myositis diagnosis market can be segmented based on disease type, test type, end user and region. Based on disease type, the market can be categorized into dermatomyositis, polymyositis and others. The polymyositis segment dominates the market as it is the most common type of inflammatory myopathy. Based on test type, the market is divided into antibodies & complement tests, electromyography, muscle biopsy, genetic tests and others. The antibodies & complement tests segment holds the largest share as it provides rapid diagnosis of inflammatory myopathies.
Global Analysis
North America holds the major share in the inflammatory myositis diagnosis market owing to the increasing incidence of autoimmune disorders, rising healthcare expenditure and advancing diagnostic technologies in the region. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to large patient pool, improving healthcare infrastructure and rising medical tourism in developing countries. Some of the major factors responsible for the growth of inflammatory myositis diagnosis market globally include increasing prevalence of inflammatory myopathies, growing awareness regarding early diagnosis, technological advancements and new product launches.
Get this Report in Japanese Language: 炎症性筋炎診断市場
Get this Report in Korean Language: 염증성 근염 진단 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
